Soleimani Atena, Khazaei Majid, Ferns Gordon A, Ryzhikov Mikhail, Avan Amir, Hassanian Seyed Mahdi
Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
J Cell Physiol. 2019 Sep;234(9):14574-14580. doi: 10.1002/jcp.28169. Epub 2019 Jan 26.
Transforming growth factor β (TGF-β) modulates tumor progression by regulating cell proliferation, apoptosis, metastasis, angiogenesis, and drug resistance. Biological and pharmacological agonists/antagonists, the interplay between intracellular signaling pathways, and microRNAs (miRNAs) control the initiation and activation of the TGF-β signaling pathway. It has been proposed that the expression profiles of tumor suppressor and oncogenic TGF-β miRNAs may be used for the classification, diagnosis, and prognosis of human malignancies. Deregulated miRNAs and aberrant activation of TGF-β signaling are frequently found in human colorectal cancers (CRCs), but a little is known about their mechanisms of action in the development and progression of colorectal carcinoma. This review summarizes the current knowledge of the role of TGF-β signaling regulatory miRNAs in the pathogenesis of CRC for a better understanding and hence better management of this disease.
转化生长因子β(TGF-β)通过调节细胞增殖、凋亡、转移、血管生成和耐药性来调控肿瘤进展。生物和药理激动剂/拮抗剂、细胞内信号通路之间的相互作用以及微小RNA(miRNA)控制着TGF-β信号通路的启动和激活。有人提出,肿瘤抑制性和致癌性TGF-β miRNA的表达谱可用于人类恶性肿瘤的分类、诊断和预后判断。miRNA失调和TGF-β信号异常激活在人类结直肠癌(CRC)中经常出现,但对于它们在结直肠癌发生和发展中的作用机制却知之甚少。这篇综述总结了目前关于TGF-β信号调节miRNA在CRC发病机制中的作用的知识,以便更好地理解并因此更好地管理这种疾病。